Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.9800
-0.0026 (-0.26%)
Aug 14, 2025, 11:38 AM - Market open
Akari Therapeutics, Stock Forecast
AKTX's stock price has decreased by -71.13% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Akari Therapeutics, stock has a target of 5.00, which predicts a 410.20% increase from the current stock price of 0.98.
Price Target: $5.00 (+410.20%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Akari Therapeutics, is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +410.20% | Jul 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +2,961.22% | Dec 5, 2022 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +8,063.27% | Nov 1, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $140 → $100 | Strong Buy | Maintains | $140 → $100 | +10,104.08% | Mar 13, 2020 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $300 → $160 | Strong Buy | Maintains | $300 → $160 | +16,226.53% | Mar 29, 2018 |
Financial Forecast
Revenue This Year
4.28M
Revenue Next Year
n/a
from 4.28M
EPS This Year
-0.46
from -1.66
EPS Next Year
-0.41
from -0.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 |
|---|---|
| High | 4.4M |
| Avg | 4.3M |
| Low | 4.1M |
Revenue Growth
| Revenue Growth | 2025 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.47 | -0.42 | -0.47 |
| Avg | -0.46 | -0.41 | -0.46 |
| Low | -0.44 | -0.39 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.